Organization
Bulgaria
2 abstracts
Abstract
A phase 2, multicenter, open-label, dose-optimization study evaluating telomere-targeting agent THIO sequenced with cemiplimab in patients with advanced NSCLC: Updated results.Org: Medical University in Lublin, Lublin, Szolnok, Hungary, Matrai Gyogyintezet,
Abstract
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES DIAGNOSTIC SENSITIVITY AND SPECIFICITY IN PATIENTS WITH VERY EARLY RHEUMATOID ARTHRITISOrg: Of Rheumatology, Universiry Hospital St George, Plivdiv, Central Clinical Laboratory, University Hospital St George,